efficacy of Kantakari and Vasa Lozenges in children with Kasa
Not Applicable
- Conditions
- Health Condition 1: J06- Acute upper respiratory infectionsof multiple and unspecified sitesHealth Condition 2: C00-D49- Neoplasms
- Registration Number
- CTRI/2021/02/031483
- Lead Sponsor
- Datta meghe institute of medical sciences deemed to be university wardha maharashtra
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Dignosed patients of kasa between the age of 5 to 14 years presenting with clincal signs and symptoms given parents consent irrespective of gender caste religion socioeconomic background
Exclusion Criteria
known cases of pneumonia bronchial asthma bronchiectasis pleurisy tuberculosis maligancyand other systemic diseases with cough
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method decreased irritability of kasaTimepoint: 3rd day and 7th day and during study <br/ ><br>Follow up post treatment â??14th& 21st day <br/ ><br>
- Secondary Outcome Measures
Name Time Method Changes in Adventitious soundTimepoint: on 21th days